273 related articles for article (PubMed ID: 35190910)
1. Site-activated multi target iron chelators with acetylcholinesterase (AChE) and monoamine oxidase (MAO) inhibitory activities for Alzheimer's disease therapy.
Youdim MBH
J Neural Transm (Vienna); 2022 Jun; 129(5-6):715-721. PubMed ID: 35190910
[TBL] [Abstract][Full Text] [Related]
2. Selective acetylcholinesterase inhibitor activated by acetylcholinesterase releases an active chelator with neurorescuing and anti-amyloid activities.
Zheng H; Youdim MB; Fridkin M
ACS Chem Neurosci; 2010 Nov; 1(11):737-46. PubMed ID: 22778810
[TBL] [Abstract][Full Text] [Related]
3. Site-activated chelators targeting acetylcholinesterase and monoamine oxidase for Alzheimer's therapy.
Zheng H; Youdim MB; Fridkin M
ACS Chem Biol; 2010 Jun; 5(6):603-10. PubMed ID: 20455574
[TBL] [Abstract][Full Text] [Related]
4. From anti-Parkinson's drug rasagiline to novel multitarget iron chelators with acetylcholinesterase and monoamine oxidase inhibitory and neuroprotective properties for Alzheimer's disease.
Zheng H; Amit T; Bar-Am O; Fridkin M; Youdim MB; Mandel SA
J Alzheimers Dis; 2012; 30(1):1-16. PubMed ID: 22387411
[TBL] [Abstract][Full Text] [Related]
5. 4,6-Diphenylpyrimidine Derivatives as Dual Inhibitors of Monoamine Oxidase and Acetylcholinesterase for the Treatment of Alzheimer's Disease.
Kumar B; Dwivedi AR; Sarkar B; Gupta SK; Krishnamurthy S; Mantha AK; Parkash J; Kumar V
ACS Chem Neurosci; 2019 Jan; 10(1):252-265. PubMed ID: 30296051
[TBL] [Abstract][Full Text] [Related]
6. Development of the "hidden" multi-target-directed ligands by AChE/BuChE for the treatment of Alzheimer's disease.
Chen R; Li X; Chen H; Wang K; Xue T; Mi J; Ban Y; Zhu G; Zhou Y; Dong W; Tang L; Sang Z
Eur J Med Chem; 2023 May; 251():115253. PubMed ID: 36921526
[TBL] [Abstract][Full Text] [Related]
7. N-alkylpiperidine carbamates as potential anti-Alzheimer's agents.
Košak U; Strašek N; Knez D; Jukič M; Žakelj S; Zahirović A; Pišlar A; Brazzolotto X; Nachon F; Kos J; Gobec S
Eur J Med Chem; 2020 Jul; 197():112282. PubMed ID: 32380361
[TBL] [Abstract][Full Text] [Related]
8. Donepezil + propargylamine + 8-hydroxyquinoline hybrids as new multifunctional metal-chelators, ChE and MAO inhibitors for the potential treatment of Alzheimer's disease.
Wang L; Esteban G; Ojima M; Bautista-Aguilera OM; Inokuchi T; Moraleda I; Iriepa I; Samadi A; Youdim MB; Romero A; Soriano E; Herrero R; Fernández Fernández AP; Ricardo-Martínez-Murillo ; Marco-Contelles J; Unzeta M
Eur J Med Chem; 2014 Jun; 80():543-61. PubMed ID: 24813882
[TBL] [Abstract][Full Text] [Related]
9. Bifunctional drug derivatives of MAO-B inhibitor rasagiline and iron chelator VK-28 as a more effective approach to treatment of brain ageing and ageing neurodegenerative diseases.
Youdim MB; Fridkin M; Zheng H
Mech Ageing Dev; 2005 Feb; 126(2):317-26. PubMed ID: 15621213
[TBL] [Abstract][Full Text] [Related]
10. Novel multifunctional neuroprotective iron chelator-monoamine oxidase inhibitor drugs for neurodegenerative diseases: in vitro studies on antioxidant activity, prevention of lipid peroxide formation and monoamine oxidase inhibition.
Zheng H; Gal S; Weiner LM; Bar-Am O; Warshawsky A; Fridkin M; Youdim MB
J Neurochem; 2005 Oct; 95(1):68-78. PubMed ID: 16181413
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis, in-silico and biological evaluation of novel chalcone-O-carbamate derivatives as multifunctional agents for the treatment of Alzheimer's disease.
Sang Z; Wang K; Shi J; Liu W; Tan Z
Eur J Med Chem; 2019 Sep; 178():726-739. PubMed ID: 31229875
[TBL] [Abstract][Full Text] [Related]
12. Site-activated chelators derived from anti-Parkinson drug rasagiline as a potential safer and more effective approach to the treatment of Alzheimer's disease.
Zheng H; Fridkin M; Youdim MB
Neurochem Res; 2010 Dec; 35(12):2117-23. PubMed ID: 20981484
[TBL] [Abstract][Full Text] [Related]
13. In vitro and in vivo Biological Evaluation of Newly Tacrine-Selegiline Hybrids as Multi-Target Inhibitors of Cholinesterases and Monoamine Oxidases for Alzheimer's Disease.
Huang ST; Luo JC; Zhong GH; Teng LP; Yang CY; Tang CL; Jing L; Zhou ZB; Liu J; Jiang N
Drug Des Devel Ther; 2024; 18():133-159. PubMed ID: 38283137
[TBL] [Abstract][Full Text] [Related]
14. Pyridoxine-resveratrol hybrids Mannich base derivatives as novel dual inhibitors of AChE and MAO-B with antioxidant and metal-chelating properties for the treatment of Alzheimer's disease.
Yang X; Qiang X; Li Y; Luo L; Xu R; Zheng Y; Cao Z; Tan Z; Deng Y
Bioorg Chem; 2017 Apr; 71():305-314. PubMed ID: 28267984
[TBL] [Abstract][Full Text] [Related]
15. Site-activated multifunctional chelator with acetylcholinesterase and neuroprotective-neurorestorative moieties for Alzheimer's therapy.
Zheng H; Youdim MB; Fridkin M
J Med Chem; 2009 Jul; 52(14):4095-8. PubMed ID: 19485411
[TBL] [Abstract][Full Text] [Related]
16. Isoquinoline alkaloids from the roots of Zanthoxylum rigidum as multi-target inhibitors of cholinesterase, monoamine oxidase A and Aβ
Plazas E; Hagenow S; Avila Murillo M; Stark H; Cuca LE
Bioorg Chem; 2020 May; 98():103722. PubMed ID: 32155491
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis and biological evaluation of novel indanones derivatives as potent acetylcholinesterase/monoamine oxidase B inhibitors.
Hu Z; Zhou S; Li J; Li X; Zhou Y; Zhu Z; Xu J; Liu J
Future Med Chem; 2023 Oct; 15(20):1823-1841. PubMed ID: 37902028
[No Abstract] [Full Text] [Related]
18. Synthesis and pharmacological evaluation of donepezil-based agents as new cholinesterase/monoamine oxidase inhibitors for the potential application against Alzheimer's disease.
Li F; Wang ZM; Wu JJ; Wang J; Xie SS; Lan JS; Xu W; Kong LY; Wang XB
J Enzyme Inhib Med Chem; 2016; 31(sup3):41-53. PubMed ID: 27384289
[TBL] [Abstract][Full Text] [Related]
19. Mechanism-based pharmacokinetics-pharmacodynamics studies of harmine and harmaline on neurotransmitters regulatory effects in healthy rats: Challenge on monoamine oxidase and acetylcholinesterase inhibition.
Jiang B; Meng L; Zou N; Wang H; Li S; Huang L; Cheng X; Wang Z; Chen W; Wang C
Phytomedicine; 2019 Sep; 62():152967. PubMed ID: 31154274
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis and biological evaluation of novel coumarin-N-benzyl pyridinium hybrids as multi-target agents for the treatment of Alzheimer's disease.
Lan JS; Ding Y; Liu Y; Kang P; Hou JW; Zhang XY; Xie SS; Zhang T
Eur J Med Chem; 2017 Oct; 139():48-59. PubMed ID: 28797883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
